Arbutus to Participate at Wedbush PacGrow Healthcare Conference
August 06 2019 - 7:30AM
Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading
Hepatitis B Virus (HBV) therapeutic solutions company, today
announced that Dr. Michael Sofia will present at the Wedbush
PacGrow Healthcare Conference on Tuesday, August 13, 2019 at 10:55
am ET in New York.
A live webcast of the fireside chat can be
accessed through the Investors section of Arbutus' website at
www.arbutusbio.com. A replay of the webcast will be
available for 90 days following the live
presentations.
About ArbutusArbutus Biopharma
Corporation is a publicly-traded (Nasdaq: ABUS) biopharmaceutical
company dedicated to discovering, developing, and commercializing a
cure for patients suffering from chronic Hepatitis B (HBV)
infection. Arbutus is developing multiple drug candidates, each of
which have the potential to improve upon the standard of care and
contribute to a curative combination regimen. For more information,
visit www.arbutusbio.com.
Contact Information
InvestorsWilliam H. Collier President and CEO
Phone: 604-419-3200 Email: ir@arbutusbio.com
MediaPam Murphy Investor Relations Consultant
Phone: 604-419-3200 Email: ir@arbutusbio.com
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Apr 2023 to Apr 2024